The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 12 drugs formulations. The drug pricing regulator has recently issued an order to fix the prices of the drugs.
The drug formulations whose prices have been fixed include Atorvastatin + Aspirin + Clopidogrel Capsule, Vildagliptin + Metformin Tablet, Vildagliptin + Metformin Tablet (Vidalog M 500), Vildagliptin + Metformin Tablet (Vidalog M 850) and Vildagliptin + Metformin Tablet (Vidalog M 1000).
According to the order, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
“In case the retail price of any of the drug formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955,” reads the order.